Does ETEPLIRSEN Cause Product communication issue? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Product communication issue have been filed in association with ETEPLIRSEN (Exondys 51). This represents 0.4% of all adverse event reports for ETEPLIRSEN.
9
Reports of Product communication issue with ETEPLIRSEN
0.4%
of all ETEPLIRSEN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product communication issue From ETEPLIRSEN?
Of the 9 reports.
Is Product communication issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ETEPLIRSEN. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does ETEPLIRSEN Cause?
Product dose omission issue (641)
No adverse event (503)
Intentional dose omission (259)
Poor venous access (162)
Device issue (156)
Pyrexia (85)
Covid-19 (83)
Malaise (56)
Cough (53)
Fall (53)
What Other Drugs Cause Product communication issue?
EVOLOCUMAB (2,341)
SEMAGLUTIDE (842)
ERENUMAB-AOOE (598)
SOMATROPIN (350)
PEGFILGRASTIM (333)
ETANERCEPT (122)
ALBUTEROL (121)
NIRMATRELVIR\RITONAVIR (70)
DENOSUMAB (68)
LEVODOPA (61)
Which ETEPLIRSEN Alternatives Have Lower Product communication issue Risk?
ETEPLIRSEN vs ETESEVIMAB
ETEPLIRSEN vs ETHACRYNIC ACID
ETEPLIRSEN vs ETHAMBUTOL
ETEPLIRSEN vs ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN
ETEPLIRSEN vs ETHANOL